Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Research Frontiers | REFR | Jan 10, 2025 | 1.69 | +0.60 |
Research Solutions | RSSS | Jan 10, 2025 | 4.05 | +2.53 |
Reservoir Media | RSVR | Jan 10, 2025 | 7.92 | -1.98 |
ReShape Lifesciences | RSLS | Jan 10, 2025 | 4.50 | -4.66 |
Resideo Technologies | REZI | Jan 10, 2025 | 21.98 | -2.57 |
ResMed | RMD | Jan 10, 2025 | 233.82 | -1.00 |
Resources Connection | RGP | Jan 10, 2025 | 8.35 | -2.22 |
Restaurant Brands International | QSR | Jan 10, 2025 | 60.88 | -2.65 |
Retail Bull 3X Direxion | RETL | Jan 10, 2025 | 9.65 | -0.92 |
Retail ETF Market Vectors | RTH | Jan 10, 2025 | 226.21 | +0.05 |
Retail Opportunity Investments | ROIC | Jan 10, 2025 | 17.35 | -0.23 |
ReTo Eco-Solutions | RETO | Jan 10, 2025 | 0.90 | +3.45 |
Retractable Technologies | RVP | Jan 10, 2025 | 0.74 | -1.61 |
REV Group | REVG | Jan 10, 2025 | 32.51 | -1.75 |
Revance Therapeutics | RVNC | Jan 10, 2025 | 3.25 | -4.13 |
Revelation Biosciences | REVB | Jan 10, 2025 | 0.53 | -8.83 |
Revelyst | GEAR | Jan 10, 2025 | 20.08 | 0.00 |
Revenueshares Largecap | RWL | Jan 10, 2025 | 98.13 | -0.88 |
Revenueshares Midcap | RWK | Jan 10, 2025 | 116.29 | -0.48 |
Revenueshares Smallcap | RWJ | Jan 10, 2025 | 44.89 | -1.71 |
Revenueshares Ultra Dividend Fund | RDIV | Jan 10, 2025 | 47.27 | -2.13 |
Reviva Pharmaceuticals | RVPH | Jan 10, 2025 | 1.88 | +0.53 |
Revolution Medicines | RVMD | Jan 10, 2025 | 41.78 | -5.94 |
Revolve Group A | RVLV | Jan 10, 2025 | 29.30 | -5.21 |
Revvity | RVTY | Jan 10, 2025 | 113.88 | -2.18 |
REX American Resources | REX | Jan 10, 2025 | 42.74 | -2.53 |
Rexford Industrial Realty | REXR | Jan 10, 2025 | 37.17 | -2.82 |
Rexford Industrial Realty B Pref | REXR-B | Jan 10, 2025 | 22.98 | -2.34 |
Rexford Industrial Realty C Pref | REXR-C | Jan 10, 2025 | 21.70 | -1.99 |
Reynolds Consumer Products | REYN | Jan 10, 2025 | 26.09 | -1.51 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.